Physician profile
Ira Lyman Mitchell
NPI 1881776078
$9,784.12
in general payments reported to CMS, 2019-2025
41 companies · $883 in 2025
The $883 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $1,657 · 2021: $1,727 · 2022: $1,367 · 2023: $1,617 · 2024: $971 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,471.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,243.77 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $807.90 | 2019-2025 | Mounjaro, Jardiance |
| Abbvie INC. | $789.35 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $730.26 | 2019-2025 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $723.91 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Pfizer INC. | $672.84 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $513.40 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $460.85 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Allergan, INC. | $426.63 | 2019-2021 | |
| Novo Nordisk INC | $357.19 | 2019-2025 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $314.21 | 2019-2025 | Trintellix |
| Novartis Pharmaceuticals Corporation | $303.42 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $241.51 | 2019-2021 | |
| Amgen INC. | $226.78 | 2019-2025 | Prolia, Evenity, Otezla |
| Scilex Pharmaceuticals INC. | $202.06 | 2022-2023 | Ztlido |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.